IGFBP7による心筋細胞ネクロプトーシス抑制と心筋修復促進機構を解明(Researchers Reveal Novel Mechanism of IGFBP7 in Suppressing Cardiomyocyte Necroptosis and Promoting Repair of Infarcted Hearts)

ad

2026-08-12 中国科学院(CAS)

中国科学院上海栄養・健康研究所の楊黄天教授らは、急性心筋梗塞(MI)後の心筋細胞死を抑制し、心機能回復を促進する新たな分子機構を解明した。研究では、インスリン様成長因子結合タンパク質7(IGFBP7)が、心筋細胞のネクロプトーシス(制御性壊死)を抑える重要な内因性因子であることを明らかにした。マウス心筋梗塞モデルではIGFBP7発現が梗塞後7日で最大となり、心筋細胞特異的IGFBP7欠損マウスではネクロプトーシスの増加、心機能悪化、瘢痕形成の増強が認められた。一方、組換えヒトIGFBP7投与はマウスおよびヒト由来心筋細胞を保護した。機構解析の結果、IGFBP7はRACK1タンパク質の分解を促進し、RIP3 mRNAの安定化を阻害することでRIP3発現を低下させ、ネクロプトーシスを抑制することが判明した。さらにRIP3欠損マウスでその作用が確認された。本研究は、虚血性心疾患に対する新たな治療標的としてIGFBP7の有用性を示し、心筋梗塞後の心臓修復機構の理解を深める成果である。


Schematic model of IGFBP7 suppressing cardiomyocyte necroptosis and promoting cardiac repair post-MI. (Image by Prof. YANG’s group)

<関連情報>

IGFBP7は心筋細胞のアポトーシスを抑制することにより、梗塞を起こした心臓の治癒を促進する IGFBP7 promotes healing of infarcted hearts via suppression of cardiomyocyte necroptosis

Qiang Li, Ping Shang, Huitong Shan, Minxia Ke, Jiliang Tan, Senle Rao, Yun Jiang, Junming Tang, Huangtian Yang
Science China Life Sciences  Available Online: Aug 7, 2026
DOI:https://doi.org/10.1007/s11427-026-3417-2

Abstract

Necroptosis is crucially involved in cardiomyocyte death during myocardial infarction (MI). However, its regulatory mechanisms have not been fully clarified. Insulin-like growth factor–binding protein 7 (IGFBP7) has been showed to contribute to hypertrophy, whereas its functions in MI hearts and MI-induced cardiomyocyte death are unclear. Here, we aimed to determine the role of IGFBP7 in MI-induced cardiomyocyte necroptosis and the mechanisms involved. IGFBP7 expression was elevated in mouse infarcted hearts and reached a peak at 7 days post-MI. The immunofluorescence staining confirmed its enhancement in the cardiomyocytes of infarcted hearts. Cardiac-specific knockout of IGFBP7 (Igfbp7CM-/-) aggravated MI-induced cardiomyocyte necroptosis, functional worsening, and scar formation, whereas intramyocardial injection of human recombinant IGFBP7 (hIGFBP7) ameliorated the injury in an IGF-independent way. Further, hIGFBP7 suppressed oxygen glucose deprivation (OGD)-induced necroptosis in adult mouse cardiomyocytes (AMCMs) and human embryonic stem cell-derived cardiomyocytes. Mechanistically, MI/OGD-induced increases of receptor for activated C kinase 1 (RACK1) and receptor-interacting protein 3 (RIP3) were downregulated by hIGFBP7 but elevated by Igfbp7CM-/-, whereas the protective effects of hIGFBP7 in MI hearts of Rip3 knockout (Rip3-/-) mice and OGD-injured Rip3-/- AMCMs remained unchanged. RNA pull-down and RNA immunoprecipitation proved the binding of RACK1 to Rip3 mRNA, leading to the prolonged half-life of Rip3 mRNA. Further analysis showed that only full-length IGFBP7 but not truncated IGFBP7 interacted with RACK1, resulting in downregulation of RACK1 protein and Rip3 mRNA, subsequently suppression of necroptosis in injured cardiomyocytes. Our data demonstrate that IGFBP7 protects hearts against MI injury by reducing cardiomyocyte death via targeting necroptosis. Its beneficial effects are at least mediated by RACK1 downregulation through binding to IGFBP7 and promotion of its degradation, subsequently destabilizing Rip3 mRNA. These findings uncover reparative effects of IGFBP7 in infarcted hearts and provide new mechanistic insights how Rip3 mRNA is downregulated by a cytokine targeting MI-induced cardiomyocyte necroptosis.

医療・健康
ad
ad
Follow
ad
タイトルとURLをコピーしました